Viagra could do more than advertised as study reveals surprising health superpower
Viagra could do more than give men a boost in the bedroom, as new research suggests it may have benefits for cancer patients.The prescription medication, which is manufactured and distributed by Viatris, is commonly used to treat erectile dysfunction by increasing blood flow during sexual stimulation.It was originally developed to treat high blood pressure and chest pain caused by reduced blood flow to the heart before researchers discovered its unexpected effect on erectile function during clinical trials.PANCREATIC CANCER VACCINE SHOWS PROMISE IN FIRST HUMAN TRIAL, PREVENTING DISEASE IN HIGH-RISK PATIENTSA new study published by the American Association for Cancer Research found that the pill may have properties that can prevent cancer from spreading.Researchers at the Weizmann Institute of Science in Israel, led by Dr. Yarden Ariav in the lab of professor Ayelet Erez, found that Viagra’s active ingredient — sildenafil, a PDE5 inhibitor — may restrict cancer metastasis, or the formation of new tumors.The team, which included scientists at the U.S.
Reported by 1 outlet — Fox News Latest. See all sources ↓
Viagra could do more than give men a boost in the bedroom, as new research suggests it may have benefits for cancer patients.The prescription medication, which is manufactured and distributed by Viatris, is commonly used to treat erectile dysfunction by increasing blood flow during sexual stimulation.It was originally developed to treat high blood pressure and chest pain caused by reduced blood flow to the heart before researchers discovered its unexpected effect on erectile function during clinical trials.PANCREATIC CANCER VACCINE SHOWS PROMISE IN FIRST HUMAN TRIAL, PREVENTING DISEASE IN HIGH-RISK PATIENTSA new study published by the American Association for Cancer Research found that the pill may have properties that can prevent cancer from spreading.Researchers at the Weizmann Institute of Science in Israel, led by Dr. Yarden Ariav in the lab of professor Ayelet Erez, found that Viagra’s active ingredient — sildenafil, a PDE5 inhibitor — may restrict cancer metastasis, or the formation of new tumors.The team, which included scientists at the U.S. National Cancer Institute, analyzed human and mouse cancer cells, genetic experiments and 20 years of health data from 5 million members of Clalit Health Services, Israel's largest nonprofit healthcare provider and health insurer. They also examined how genes, proteins, fats, cholesterol and cellular energy interact.The analysis revealed that sildenafil limits the cancer cell’s ability to make use of cholesterol, which is an important mechanism in how the cell breaks away from the primary tumor and migrates throughout the body, according to a press release from the American Committee for the Weizmann Institute of Science.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERSildenafil was found to block an enzyme called phosphodiesterase type 5, or PDE5, and increase the signaling molecule called cGMP, which dilates blood vessels – the feature that has made Viagra a successful treatment for erectile dysfunction.According to the researchers, cGMP also binds to a protein that transports cholesterol within cells, reducing the cholesterol available for essential cellular functions.
Read the full report at Fox News Latest ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- Viagra could do more than give men a boost in the bedroom, as new research suggests it may have benefits for cancer patients.The prescription medication, which is manufactured and distributed by Viatris, is commonly used to treat erectile dysfunction by increasing blood flow during sexual stimulation.It was originally developed to treat high blood pressure and chest pain caused by reduced blood flow to the heart before researchers discovered its unexpected effect on erectile function during clinical trials.PANCREATIC CANCER VACCINE SHOWS PROMISE IN FIRST HUMAN TRIAL, PREVENTING DISEASE IN HIGH-RISK PATIENTSA new study published by the American Association for Cancer Research found that the pill may have properties that can prevent cancer from spreading.Researchers at the Weizmann Institute of Science in Israel, led by Dr. Yarden Ariav in the lab of professor Ayelet Erez, found that Viagra’s active ingredient — sildenafil, a PDE5 inhibitor — may restrict cancer metastasis, or the formation of new tumors.The team, which included scientists at the U.S.
- How widely is it covered?
- 1 outlet, average source rating 6.0/10.
- When was it last updated?
- 2m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Viagra could do more than advertised as study reveals surprising health superpower
Sources1TypeCoverageFox News Latest